The Task Force on Catastrophic Antiphospholipid Syndrome (CAPS) aimed to assess the current knowledge on pathogenesis, clinical and laboratory features, diagnosis and classification, precipitating factors and treatment of CAPS. This article summarizes the main aspects of its final report.
CerveraRRodríguez-PintóIColafrancescoS. 14th International Congress on Antiphospholipid Antibodies Task Force Report on Catastrophic Antiphospholipid Syndrome. Autoimmun Rev2014; 13: 699–707.
2.
KitchensCS. Thrombotic storm: When thrombosis begets thrombosis. Am J Med1998; 104: 381–385.
3.
CerveraRBucciarelliSPlasínMA. Catastrophic antiphospholipid syndrome (CAPS): Descriptive analysis of a series of 280 patients from the “CAPS Registry”. J Autoimmun2009; 32: 240–245.
4.
EspinosaGBucciarelliSCerveraRGómez-PuertaJAFontJ. Laboratory studies on pathophysiology of the catastrophic antiphospholipid syndrome. Autoimmun Rev2006; 6: 68–71.
5.
Agmon-LevinNRosárioCKatzB-SP. Ferritin in the antiphospholipid syndrome and its catastrophic variant (cAPS). Lupus2013; 22: 1327–1335.
6.
CerveraRTektonidouMGEspinosaG. Task Force on Catastrophic Antiphospholipid Syndrome (APS) and Non-criteria APS Manifestations (I): Catastrophic APS, APS nephropathy and heart valve lesions. Lupus2011; 20: 165–173.
7.
De RunzAZuilySGossetJWahlDSimonE. Particular catastrophic antiphospholipid syndrome, on the sole surgical site after breast reduction. J Plast Reconstr Aesthet Surg2013; 66: e321–e324.
8.
KatikireddiVSKandiahDA. Progression of antiphospholipid antibody syndrome to catastrophic antiphospholipid antibody syndrome acutely with cessation of antithrombotic therapy. Intern Med J2012; 42: 585–591.
9.
AmitalHLevyYDavidsonC. Catastrophic antiphospholipid syndrome: Remission following leg amputation in 2 cases. Semin Arthritis Rheum2001; 31: 127–132.
10.
BaronTHKamathPSMcBaneRD. Management of antithrombotic therapy in patients undergoing invasive procedures. N Engl J Med2013; 368: 2113–2124.
11.
CerveraR. Update on the diagnosis, treatment, and prognosis of the catastrophic antiphospholipid syndrome. Curr Rheumatol Rep2010; 12: 70–76.
12.
BucciarelliSEspinosaGCerveraR. Mortality in the catastrophic antiphospholipid syndrome: Causes of death and prognostic factors in a series of 250 patients. Arthritis Rheum2006; 54: 2568–2576.
13.
AshersonRACerveraR. The catastrophic antiphospholipid syndrome: A review of pathogenesis, clinical features and treatment. Isr Med Assoc J2000; 2: 268–273.
